Citrulline function

Certain amino acids and their derivatives, although not found in proteins, nonetheless are biochemically important. A few of the more notable examples are shown in Figure 4.5. y-Aminobutyric acid, or GABA, is produced by the decarboxylation of glutamic acid and is a potent neurotransmitter. Histamine, which is synthesized by decarboxylation of histidine, and serotonin, which is derived from tryptophan, similarly function as neurotransmitters and regulators. /3-Alanine is found in nature in the peptides carnosine and anserine and is a component of pantothenic acid (a vitamin), which is a part of coenzyme A. Epinephrine (also known as adrenaline), derived from tyrosine, is an important hormone. Penicillamine is a constituent of the penicillin antibiotics. Ornithine, betaine, homocysteine, and homoserine are important metabolic intermediates. Citrulline is the immediate precursor of arginine. 

This enzyme [EC 3.5.3.12], also known as agmatine imi-nohydrolase, catalyzes the hydrolysis of agmatine to produce A/ -carbamoylputrescine and ammonia. The plant enzyme also catalyzes the reactions of EC 2.1.3.3 (ornithine carbamoyltransferase), EC 2.1.3.6 (putrescine car-bamoyltransferase) and EC 2.122 (carbamate kinase), thereby functioning as a putrescine synthase, converting agmatine and ornithine into putrescine and citrulline, respectively. 

CFS patients and is related to autonomic dysfunction. In a separate rat study, Giannesini et al. used citrulline malate (CM) to treat asthenia and found that the supplementation prevented the basal PCr/ATP ratio reduction and normalized the pHi time-course during muscular activ-ity. They conclude that CM supplementation corrects the impaired control of oxidative function and has protective effect on basal energy metabolism. The data from either human or animal studies provide a potential approach to therapy. 

Several lines of investigation assert to the inability of canal ine to function as an effective ornithine antagonist. Ornithine interaction with canaline has been evaluated with the ornithine carbamoyl transferase (EC 2.1.3.3) of human liver. Neither canal ine nor ornithine inhibited this enzyme when the other member of this set served as the carbamoyl group recipient (29). The ornithine antagonist, 2,4-diaminobutyric acid drastically reduced urea production in the rat this reflected curtailment of the ornithine carbamoyl transferase-mediated conversion of ornithine to citrulline. Yet, canaline had no such effect on urea formation in this mammal (30). 

Schematic illustration of the interrelationships between glutamate and NO in synaptic function in the cetebellum. The presynaptic nerve terminal synthesizes, stores, and releases glutamate (G) as the neurotransmitter by exocytosis as illustrated. The glutamate diffu.ses across the synaptic cleft and interacts with postsynaptic NMDA recepti>rs ( ) that are coupled to calcium (Ca ) channels. Ca influx occurs and the free intracellular Ca complexes with calmtxlulin and activates NO synthase. NADPH is also required hir conversion, and the products of the reaction are NO plus L-citrulline. NO diffuses out of the piistsynaptic cell to interact with nearby target cells, one of which is the presynaptic neuron that released the glutamate in the first place. NO stimulates cytosolic guanylate cyclase and cyclic GMP (cGMP) formation presynaptically, hut the consequence of this pre.synaptic modification is unknown.

Some 300 additional amino acids have been found in cells. They have a variety of functions but are not constituents of proteins. Ornithine and citrulline... 

FIGURE 3-8 Uncommon amino acids, (a) Some uncommon amino acids found in proteins. All are derived from common amino acids. Extra functional groups added by modification reactions are shown in red. Desmosine is formed from four Lys residues (the four carbon backbones are shaded in yellow). Note the use of either numbers or Creek letters to identify the carbon atoms in these structures, (b) Ornithine and citrulline, which are not found in proteins, are intermediates in the biosynthesis of arginine and in the urea cycle. 

The carbamoyl phosphate, which functions as an activated carbamoyl group donor, now enters the urea cycle. The cycle has four enzymatic steps. First, carbamoyl phosphate donates its carbamoyl group to ornithine to form citrulline, with the release of Pj (Fig. 18-10, step ). Ornithine plays a role resembling that of oxaloacetate in the citric acid cycle, accepting material at each turn of the cycle. The reaction is catalyzed by ornithine transcarbamoylase, and the citrulline passes from the mitochondrion to the cytosol. 

The complete urea cycle as it occurs in the mammalian liver requires five enzymes Argininosuccinate synthase, arginase, and argininosuccinate lyase (which function in the cytosol), and ornithine transcarbamoylase, and carbamoyl phosphate synthase (which function in the mitochondria). Additional specific transport proteins are required for the mitochondrial uptake of L-ornithine, NH3, and HC03 and for the release of L-citrulline. 

In some cases, the function of the metal ion is more to deactivate alternative sites of reaction than to activate a particular atom towards attack by an electrophile. A good example of this is seen in the transamination reaction of ornithine (5.12) with urea. Co-ordination of the ornithine to copper(n) results in the formation of a five-membered chelate ring, leaving the amino group of the 3-aminopropyl substituent as the most nucleophilic site in the complex. Reaction of this complex with urea results in a transamination process and the formation of the copper(n) complex of the substituted urea, which is the amino acid citrulline (5.13) (Fig. 5-20). The complex may be demetallated to yield the free amino acid in respectable yields. 

The most abundant amino add in the human organism does not occur in proteins and does not have a carboxyl group. Its addic residue is the sulfonate group, and its name is taurine (N+H3-CH2-CH2-S03 ). It occurs in the free state (exact function often unknown) and in bile salts, in which it plays an important role in fat digestion and absorption (see Chapters 9 and 19). Other amino acids that do not occur in proteins are ornithine and citrulline. They are important intermediates in the urea cycle described in Chapter 20. 

Figure 2 Stoichiometry of the enzymatic mechanism of formation of NO, and the structure of a competitive inhibitor, N -monomethyl-L-arginine (NMMA). NO is synthesized by all NOS s by a similar mechanism, involving the NADPH-dependent mixed-function oxidation of a guanidino nitrogen of the amino acid L-arginine (L-arg) to produce L-citrulline (L-cit) and -NO. The nonintegral stoichiometries are explained in the text. NMMA inhibits NOS as a competitive inhibitor...

---